Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

Mapping and Making Sense of Noncoding Mutations in the Genome.

Yang J, Adli M.

Cancer Res. 2019 Sep 1;79(17):4309-4314. doi: 10.1158/0008-5472.CAN-19-0905. Epub 2019 Aug 6. Review.

PMID:
31387922
2.
3.

Chemotherapy-Induced Distal Enhancers Drive Transcriptional Programs to Maintain the Chemoresistant State in Ovarian Cancer.

Shang S, Yang J, Jazaeri AA, Duval AJ, Tufan T, Lopes Fischer N, Benamar M, Guessous F, Lee I, Campbell RM, Ebert PJ, Abbas T, Landen CN, Difeo A, Scacheri PC, Adli M.

Cancer Res. 2019 Sep 15;79(18):4599-4611. doi: 10.1158/0008-5472.CAN-19-0215. Epub 2019 Jul 29.

PMID:
31358529
4.

Remission in schizophrenia - What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depression.

Schennach R, Obermeier M, Spellmann I, Seemüller F, Musil R, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Bauer M, Adli M, Zeiler J, Bender W, Kronmüller KT, Ising M, Brieger P, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ, Riedel M.

Schizophr Res. 2019 Jul;209:185-192. doi: 10.1016/j.schres.2019.04.022. Epub 2019 May 25.

PMID:
31138482
5.

Treatment response of lithium augmentation in geriatric compared to non-geriatric patients with treatment-resistant depression.

Buspavanich P, Behr J, Stamm T, Schlattmann P, Bschor T, Richter C, Hellweg R, Heinz A, Berger M, Hindinger C, Rentzsch J, de Millas W, Jockers-Scherübl MC, Bräunig P, Adli M, Ricken R.

J Affect Disord. 2019 May 15;251:136-140. doi: 10.1016/j.jad.2019.03.057. Epub 2019 Mar 20.

PMID:
30921597
6.

Leptin gene polymorphisms are associated with weight gain during lithium augmentation in patients with major depression.

Bopp SK, Heilbronner U, Schlattmann P, Mühleisen TW, Bschor T, Richter C, Steinacher B, Stamm TJ, Merkl A, Herms S, Köhler S, Sterzer P, Hellweg R, Heinz A, Cichon S, Lang UE, Schulze TG, Adli M, Ricken R.

Eur Neuropsychopharmacol. 2019 Dec;29(2):211-221. doi: 10.1016/j.euroneuro.2018.12.006. Epub 2018 Dec 13.

PMID:
30554862
7.

Masters or pawns? Examining injury and chronic disease in male Masters Athletes and chess players compared to population norms from the Canadian Community Health Survey.

Patelia S, Stone RC, El-Bakri R, Adli M, Baker J.

Eur Rev Aging Phys Act. 2018 Nov 30;15:15. doi: 10.1186/s11556-018-0204-z. eCollection 2018.

8.

The Biology and Application Areas of CRISPR Technologies.

Adli M.

J Mol Biol. 2019 Jan 4;431(1):1-2. doi: 10.1016/j.jmb.2018.11.012. Epub 2018 Nov 14. No abstract available.

PMID:
30447221
9.

Recurrent mutations at estrogen receptor binding sites alter chromatin topology and distal gene expression in breast cancer.

Yang J, Wei X, Tufan T, Kuscu C, Unlu H, Farooq S, Demirtas E, Paschal BM, Adli M.

Genome Biol. 2018 Nov 7;19(1):190. doi: 10.1186/s13059-018-1572-4.

10.

CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response.

Szlachta K, Kuscu C, Tufan T, Adair SJ, Shang S, Michaels AD, Mullen MG, Fischer NL, Yang J, Liu L, Trivedi P, Stelow EB, Stukenberg PT, Parsons JT, Bauer TW, Adli M.

Nat Commun. 2018 Oct 15;9(1):4275. doi: 10.1038/s41467-018-06676-2.

11.

Effect of PET/CT standardized uptake values on complete response to treatment before definitive chemoradiotherapy in stage III non-small cell lung cancer.

Ercelep O, Alan O, Sahin D, Telli TA, Salva H, Tuylu TB, Babacan NA, Kaya S, Dane F, Ones T, Alkis H, Adli M, Yumuk F.

Clin Transl Oncol. 2019 Apr;21(4):499-504. doi: 10.1007/s12094-018-1949-6. Epub 2018 Sep 18.

PMID:
30229391
12.

Super-enhancers maintain renin-expressing cell identity and memory to preserve multi-system homeostasis.

Martinez MF, Medrano S, Brown EA, Tufan T, Shang S, Bertoncello N, Guessoum O, Adli M, Belyea BC, Sequeira-Lopez MLS, Gomez RA.

J Clin Invest. 2018 Nov 1;128(11):4787-4803. doi: 10.1172/JCI121361. Epub 2018 Oct 2.

13.

Temporal and Spatial Epigenome Editing Allows Precise Gene Regulation in Mammalian Cells.

Kuscu C, Mammadov R, Czikora A, Unlu H, Tufan T, Fischer NL, Arslan S, Bekiranov S, Kanemaki M, Adli M.

J Mol Biol. 2019 Jan 4;431(1):111-121. doi: 10.1016/j.jmb.2018.08.001. Epub 2018 Aug 9.

PMID:
30098338
14.

Algorithms For Treatment of Major Depressive Disorder: Efficacy and Cost-Effectiveness.

Bauer M, Rush AJ, Ricken R, Pilhatsch M, Adli M.

Pharmacopsychiatry. 2019 Mar;52(3):117-125. doi: 10.1055/a-0643-4830. Epub 2018 Jul 9. Review.

PMID:
29986372
15.

Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study.

Kalman JL, Papiol S, Forstner AJ, Heilbronner U, Degenhardt F, Strohmaier J, Adli M, Adorjan K, Akula N, Alda M, Anderson-Schmidt H, Andlauer TF, Anghelescu IG, Ardau R, Arias B, Arolt V, Aubry JM, Backlund L, Bartholdi K, Bauer M, Baune BT, Becker T, Bellivier F, Benabarre A, Bengesser S, Bhattacharjee AK, Biernacka JM, Birner A, Brichant-Petitjean C, Budde M, Cervantes P, Chillotti C, Cichon S, Clark SR, Colom F, Comes AL, Cruceanu C, Czerski PM, Dannlowski U, Dayer A, Del Zompo M, DePaulo JR, Dietrich DE, Étain B, Ethofer T, Falkai P, Fallgatter A, Figge C, Flatau L, Folkerts H, Frisen L, Frye MA, Fullerton JM, Gade K, Gard S, Garnham JS, Goes FS, Grigoroiu-Serbanescu M, Gryaznova A, Hake M, Hauser J, Herms S, Hoffmann P, Hou L, Jäger M, Jamain S, Jiménez E, Juckel G, Kahn JP, Kassem L, Kelsoe J, Kittel-Schneider S, Kliwicki S, Klohn-Sagatholislam F, Koller M, König B, Konrad C, Lackner N, Laje G, Landén M, Lang FU, Lavebratt C, Leboyer M, Leckband SG, Maj M, Manchia M, Martinsson L, McCarthy MJ, McElroy SL, McMahon FJ, Mitchell PB, Mitjans M, Mondimore FM, Monteleone P, Nieratschker V, Nievergelt CM, Novák T, Ösby U, Pfennig A, Potash JB, Reich-Erkelenz D, Reif A, Reimer J, Reininghaus E, Reitt M, Ripke S, Rouleau GA, Rybakowski JK, Schalling M, Scherk H, Schmauß M, Schofield PR, Schubert KO, Schulte EC, Schulz S, Senner F, Severino G, Shekhtman T, Shilling PD, Simhandl C, Slaney CM, Spitzer C, Squassina A, Stamm T, Stegmaier S, Stierl S, Stopkova P, Thiel A, Tighe SK, Tortorella A, Turecki G, Vieta E, Veeh J, von Hagen M, Wigand ME, Wiltfang J, Witt S, Wright A, Zandi PP, Zimmermann J, Nöthen M, Rietschel M, Schulze TG.

Bipolar Disord. 2019 Feb;21(1):68-75. doi: 10.1111/bdi.12659. Epub 2018 Jun 28.

16.

Analysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder.

Reinbold CS, Forstner AJ, Hecker J, Fullerton JM, Hoffmann P, Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N, Ardau R, Arias B, Backlund L, Benabarre A, Bengesser S, Bhattacharjee AK, Biernacka JM, Birner A, Marie-Claire C, Cervantes P, Chen GB, Chen HC, Chillotti C, Clark SR, Colom F, Cousins DA, Cruceanu C, Czerski PM, Dayer A, Étain B, Falkai P, Frisén L, Gard S, Garnham JS, Goes FS, Grof P, Gruber O, Hashimoto R, Hauser J, Herms S, Jamain S, Jiménez E, Kahn JP, Kassem L, Kittel-Schneider S, Kliwicki S, König B, Kusumi I, Lackner N, Laje G, Landén M, Lavebratt C, Leboyer M, Leckband SG, López Jaramillo CA, MacQueen G, Manchia M, Martinsson L, Mattheisen M, McCarthy MJ, McElroy SL, Mitjans M, Mondimore FM, Monteleone P, Nievergelt CM, Ösby U, Ozaki N, Perlis RH, Pfennig A, Reich-Erkelenz D, Rouleau GA, Schofield PR, Schubert KO, Schweizer BW, Seemüller F, Severino G, Shekhtman T, Shilling PD, Shimoda K, Simhandl C, Slaney CM, Smoller JW, Squassina A, Stamm TJ, Stopkova P, Tighe SK, Tortorella A, Turecki G, Volkert J, Witt SH, Wright AJ, Young LT, Zandi PP, Potash JB, DePaulo JR, Bauer M, Reininghaus E, Novák T, Aubry JM, Maj M, Baune BT, Mitchell PB, Vieta E, Frye MA, Rybakowski JK, Kuo PH, Kato T, Grigoroiu-Serbanescu M, Reif A, Del Zompo M, Bellivier F, Schalling M, Wray NR, Kelsoe JR, Alda M, McMahon FJ, Schulze TG, Rietschel M, Nöthen MM, Cichon S.

Front Psychiatry. 2018 May 31;9:207. doi: 10.3389/fpsyt.2018.00207. eCollection 2018.

17.

CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool.

Brokowski C, Adli M.

J Mol Biol. 2019 Jan 4;431(1):88-101. doi: 10.1016/j.jmb.2018.05.044. Epub 2018 Jun 7. Review.

PMID:
29885329
18.

The CRISPR tool kit for genome editing and beyond.

Adli M.

Nat Commun. 2018 May 15;9(1):1911. doi: 10.1038/s41467-018-04252-2. Review.

19.

Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorder.

Musil R, Seemüller F, Meyer S, Spellmann I, Adli M, Bauer M, Kronmüller KT, Brieger P, Laux G, Bender W, Heuser I, Fisher R, Gaebel W, Schennach R, Möller HJ, Riedel M.

Int J Methods Psychiatr Res. 2018 Mar;27(1). doi: 10.1002/mpr.1569. Epub 2017 Jun 14.

PMID:
29498147
20.

Chronotype is associated with psychological well-being depending on the composition of the study sample.

Dimitrov A, Veer IM, Kleeblatt J, Seyfarth F, Roenneberg T, Ising M, Uhr M, Keck ME, Kramer A, Berger M, von Koch L, Walter H, Adli M.

J Health Psychol. 2018 Jan 1:1359105317751618. doi: 10.1177/1359105317751618. [Epub ahead of print]

PMID:
29357698
21.

A standardized stepwise drug treatment algorithm for depression reduces direct treatment costs in depressed inpatients - Results from the German Algorithm Project (GAP3).

Ricken R, Wiethoff K, Reinhold T, Stamm TJ, Baghai TC, Fisher R, Seemüller F, Brieger P, Cordes J, Laux G, Hauth I, Möller HJ, Heinz A, Bauer M, Adli M.

J Affect Disord. 2018 Mar 1;228:173-177. doi: 10.1016/j.jad.2017.11.051. Epub 2017 Nov 13.

PMID:
29253683
22.

Development and challenges of palliative care in Indonesia: role of psychosomatic medicine.

Putranto R, Mudjaddid E, Shatri H, Adli M, Martina D.

Biopsychosoc Med. 2017 Nov 21;11:29. doi: 10.1186/s13030-017-0114-8. eCollection 2017. Review.

23.

Prognostic value of pre-treatment 18F-FDG PET uptake for nasopharyngeal carcinoma.

Aktan M, Kanyilmaz G, Yavuz BB, Koc M, Eryılmaz MA, Adli M.

Radiol Med. 2017 Nov 25. doi: 10.1007/s11547-017-0837-4. [Epub ahead of print]

PMID:
29177728
24.

Transgenerational Effects of Bisphenol A on Gene Expression and DNA Methylation of Imprinted Genes in Brain.

Drobná Z, Henriksen AD, Wolstenholme JT, Montiel C, Lambeth PS, Shang S, Harris EP, Zhou C, Flaws JA, Adli M, Rissman EF.

Endocrinology. 2018 Jan 1;159(1):132-144. doi: 10.1210/en.2017-00730.

25.

Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study.

International Consortium on Lithium Genetics (ConLi+Gen), Amare AT, Schubert KO, Hou L, Clark SR, Papiol S, Heilbronner U, Degenhardt F, Tekola-Ayele F, Hsu YH, Shekhtman T, Adli M, Akula N, Akiyama K, Ardau R, Arias B, Aubry JM, Backlund L, Bhattacharjee AK, Bellivier F, Benabarre A, Bengesser S, Biernacka JM, Birner A, Brichant-Petitjean C, Cervantes P, Chen HC, Chillotti C, Cichon S, Cruceanu C, Czerski PM, Dalkner N, Dayer A, Del Zompo M, DePaulo JR, Étain B, Falkai P, Forstner AJ, Frisen L, Frye MA, Fullerton JM, Gard S, Garnham JS, Goes FS, Grigoroiu-Serbanescu M, Grof P, Hashimoto R, Hauser J, Herms S, Hoffmann P, Hofmann A, Jamain S, Jiménez E, Kahn JP, Kassem L, Kuo PH, Kato T, Kelsoe J, Kittel-Schneider S, Kliwicki S, König B, Kusumi I, Laje G, Landén M, Lavebratt C, Leboyer M, Leckband SG, Tortorella A, Manchia M, Martinsson L, McCarthy MJ, McElroy S, Colom F, Mitjans M, Mondimore FM, Monteleone P, Nievergelt CM, Nöthen MM, Novák T, O'Donovan C, Ozaki N, Ösby U, Pfennig A, Potash JB, Reif A, Reininghaus E, Rouleau GA, Rybakowski JK, Schalling M, Schofield PR, Schweizer BW, Severino G, Shilling PD, Shimoda K, Simhandl C, Slaney CM, Squassina A, Stamm T, Stopkova P, Maj M, Turecki G, Vieta E, Volkert J, Witt S, Wright A, Zandi PP, Mitchell PB, Bauer M, Alda M, Rietschel M, McMahon FJ, Schulze TG, Baune BT.

JAMA Psychiatry. 2018 Jan 1;75(1):65-74. doi: 10.1001/jamapsychiatry.2017.3433.

26.

Corrigendum to: "Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers" [EBioMedicine 8 (2016) 117-131].

Illendula A, Gilmour J, Grembecka J, Tirumala VSS, Boulton A, Kuntimaddi A, Schmidt C, Wang L, Pulikkan JA, Zong H, Parlak M, Kuscu C, Pickin A, Zhou Y, Gao Y, Mishra L, Adli M, Castilla LH, Rajewski RA, Janes KA, Guzman ML, Bonifer C, Bushweller JH.

EBioMedicine. 2017 Nov;25:188. doi: 10.1016/j.ebiom.2017.10.029. Epub 2017 Oct 31. No abstract available.

27.

Cytokine serum levels remain unchanged during lithium augmentation of antidepressants in major depression.

Ricken R, Busche M, Schlattmann P, Himmerich H, Bopp S, Bschor T, Richter C, Stamm TJ, Heinz A, Hellweg R, Lang UE, Adli M.

J Psychiatr Res. 2018 Jan;96:203-208. doi: 10.1016/j.jpsychires.2017.10.002. Epub 2017 Oct 5.

PMID:
29101798
28.

Ghrelin Serum Concentrations Are Associated with Treatment Response During Lithium Augmentation of Antidepressants.

Ricken R, Bopp S, Schlattmann P, Himmerich H, Bschor T, Richter C, Elstner S, Stamm TJ, Schulz-Ratei B, Lingesleben A, Reischies FM, Sterzer P, Borgwardt S, Bauer M, Heinz A, Hellweg R, Lang UE, Adli M.

Int J Neuropsychopharmacol. 2017 Sep 1;20(9):692-697. doi: 10.1093/ijnp/pyw082.

29.

Improving functional outcome in bipolar disorder: A pilot study on metacognitive training.

Haffner P, Quinlivan E, Fiebig J, Sondergeld LM, Strasser ES, Adli M, Moritz S, Stamm TJ.

Clin Psychol Psychother. 2018 Jan;25(1):50-58. doi: 10.1002/cpp.2124. Epub 2017 Aug 30.

PMID:
28857347
30.

Discharge management strategies and post-discharge care interventions for depression - Systematic review and meta-analysis.

Holzinger F, Fahrenkrog S, Roll S, Kleefeld F, Adli M, Heintze C.

J Affect Disord. 2017 Dec 1;223:82-94. doi: 10.1016/j.jad.2017.07.026. Epub 2017 Jul 11. Review.

PMID:
28734149
31.

Tranylcypromine in mind (Part I): Review of pharmacology.

Ulrich S, Ricken R, Adli M.

Eur Neuropsychopharmacol. 2017 Aug;27(8):697-713. doi: 10.1016/j.euroneuro.2017.05.007. Epub 2017 Jun 24. Review.

32.

How Effective Is Algorithm-Guided Treatment for Depressed Inpatients? Results from the Randomized Controlled Multicenter German Algorithm Project 3 Trial.

Adli M, Wiethoff K, Baghai TC, Fisher R, Seemüller F, Laakmann G, Brieger P, Cordes J, Malevani J, Laux G, Hauth I, Möller HJ, Kronmüller KT, Smolka MN, Schlattmann P, Berger M, Ricken R, Stamm TJ, Heinz A, Bauer M.

Int J Neuropsychopharmacol. 2017 Sep 1;20(9):721-730. doi: 10.1093/ijnp/pyx043.

33.

CRISPR-STOP: gene silencing through base-editing-induced nonsense mutations.

Kuscu C, Parlak M, Tufan T, Yang J, Szlachta K, Wei X, Mammadov R, Adli M.

Nat Methods. 2017 Jul;14(7):710-712. doi: 10.1038/nmeth.4327. Epub 2017 Jun 5.

PMID:
28581493
34.

Tranylcypromine in mind (Part II): Review of clinical pharmacology and meta-analysis of controlled studies in depression.

Ricken R, Ulrich S, Schlattmann P, Adli M.

Eur Neuropsychopharmacol. 2017 Aug;27(8):714-731. doi: 10.1016/j.euroneuro.2017.04.003. Epub 2017 Jun 1. Review.

35.

Cities and Mental Health.

Gruebner O, Rapp MA, Adli M, Kluge U, Galea S, Heinz A.

Dtsch Arztebl Int. 2017 Feb 24;114(8):121-127. doi: 10.3238/arztebl.2017.0121. Review.

36.

Live cell imaging of low- and non-repetitive chromosome loci using CRISPR-Cas9.

Qin P, Parlak M, Kuscu C, Bandaria J, Mir M, Szlachta K, Singh R, Darzacq X, Yildiz A, Adli M.

Nat Commun. 2017 Mar 14;8:14725. doi: 10.1038/ncomms14725.

37.

Neurourbanism: towards a new discipline.

Adli M, Berger M, Brakemeier EL, Engel L, Fingerhut J, Gomez-Carrillo A, Hehl R, Heinz A, H JM, Mehran N, Tolaas S, Walter H, Weiland U, Stollmann J.

Lancet Psychiatry. 2017 Mar;4(3):183-185. doi: 10.1016/S2215-0366(16)30371-6. No abstract available.

PMID:
28236944
38.

CRISPR-Cas9-AID base editor is a powerful gain-of-function screening tool.

Kuscu C, Adli M.

Nat Methods. 2016 Nov 29;13(12):983-984. doi: 10.1038/nmeth.4076. No abstract available.

PMID:
27898061
39.

Evolution of Osteocrin as an activity-regulated factor in the primate brain.

Ataman B, Boulting GL, Harmin DA, Yang MG, Baker-Salisbury M, Yap EL, Malik AN, Mei K, Rubin AA, Spiegel I, Durresi E, Sharma N, Hu LS, Pletikos M, Griffith EC, Partlow JN, Stevens CR, Adli M, Chahrour M, Sestan N, Walsh CA, Berezovskii VK, Livingstone MS, Greenberg ME.

Nature. 2016 Nov 10;539(7628):242-247. doi: 10.1038/nature20111.

40.

Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studies.

Spellmann I, Schennach R, Seemüller F, Meyer S, Musil R, Jäger M, Schmauß M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Bauer M, Adli M, Zeiler J, Bender W, Kronmüller KT, Ising M, Brieger P, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Riedel M, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2017 Jun;267(4):303-313. doi: 10.1007/s00406-016-0741-2. Epub 2016 Oct 26.

PMID:
27785605
41.

Behavioral measures and self-report of impulsivity in bipolar disorder: no association between Stroop test and Barratt Impulsiveness Scale.

Strasser ES, Haffner P, Fiebig J, Quinlivan E, Adli M, Stamm TJ.

Int J Bipolar Disord. 2016 Dec;4(1):16. doi: 10.1186/s40345-016-0057-1. Epub 2016 Aug 17.

42.

Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers.

Illendula A, Gilmour J, Grembecka J, Tirumala VSS, Boulton A, Kuntimaddi A, Schmidt C, Wang L, Pulikkan JA, Zong H, Parlak M, Kuscu C, Pickin A, Zhou Y, Gao Y, Mishra L, Adli M, Castilla LH, Rajewski RA, Janes KA, Guzman ML, Bonifer C, Bushweller JH.

EBioMedicine. 2016 Jun;8:117-131. doi: 10.1016/j.ebiom.2016.04.032. Epub 2016 Apr 29. Erratum in: EBioMedicine. 2017 Nov;25:188.

43.

Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder.

Hou L, Bergen SE, Akula N, Song J, Hultman CM, Landén M, Adli M, Alda M, Ardau R, Arias B, Aubry JM, Backlund L, Badner JA, Barrett TB, Bauer M, Baune BT, Bellivier F, Benabarre A, Bengesser S, Berrettini WH, Bhattacharjee AK, Biernacka JM, Birner A, Bloss CS, Brichant-Petitjean C, Bui ET, Byerley W, Cervantes P, Chillotti C, Cichon S, Colom F, Coryell W, Craig DW, Cruceanu C, Czerski PM, Davis T, Dayer A, Degenhardt F, Del Zompo M, DePaulo JR, Edenberg HJ, Étain B, Falkai P, Foroud T, Forstner AJ, Frisén L, Frye MA, Fullerton JM, Gard S, Garnham JS, Gershon ES, Goes FS, Greenwood TA, Grigoroiu-Serbanescu M, Hauser J, Heilbronner U, Heilmann-Heimbach S, Herms S, Hipolito M, Hitturlingappa S, Hoffmann P, Hofmann A, Jamain S, Jiménez E, Kahn JP, Kassem L, Kelsoe JR, Kittel-Schneider S, Kliwicki S, Koller DL, König B, Lackner N, Laje G, Lang M, Lavebratt C, Lawson WB, Leboyer M, Leckband SG, Liu C, Maaser A, Mahon PB, Maier W, Maj M, Manchia M, Martinsson L, McCarthy MJ, McElroy SL, McInnis MG, McKinney R, Mitchell PB, Mitjans M, Mondimore FM, Monteleone P, Mühleisen TW, Nievergelt CM, Nöthen MM, Novák T, Nurnberger JI Jr, Nwulia EA, Ösby U, Pfennig A, Potash JB, Propping P, Reif A, Reininghaus E, Rice J, Rietschel M, Rouleau GA, Rybakowski JK, Schalling M, Scheftner WA, Schofield PR, Schork NJ, Schulze TG, Schumacher J, Schweizer BW, Severino G, Shekhtman T, Shilling PD, Simhandl C, Slaney CM, Smith EN, Squassina A, Stamm T, Stopkova P, Streit F, Strohmaier J, Szelinger S, Tighe SK, Tortorella A, Turecki G, Vieta E, Volkert J, Witt SH, Wright A, Zandi PP, Zhang P, Zollner S, McMahon FJ.

Hum Mol Genet. 2016 Aug 1;25(15):3383-3394. doi: 10.1093/hmg/ddw181. Epub 2016 Jun 21.

44.

Leptin serum concentrations are associated with weight gain during lithium augmentation.

Ricken R, Bopp S, Schlattmann P, Himmerich H, Bschor T, Richter C, Stamm TJ, Bauer F, Heinz A, Hellweg R, Lang UE, Adli M.

Psychoneuroendocrinology. 2016 Sep;71:31-5. doi: 10.1016/j.psyneuen.2016.04.013. Epub 2016 May 11.

PMID:
27235637
45.

Stability of remission rates in a 3-year follow-up of naturalistic treated depressed inpatients.

Seemüller F, Obermeier M, Schennach R, Bauer M, Adli M, Brieger P, Laux G, Riedel M, Falkai P, Möller HJ.

BMC Psychiatry. 2016 May 20;16:153. doi: 10.1186/s12888-016-0851-4.

46.

Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study.

Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N, Ardau R, Arias B, Backlund L, Banzato CEM, Benabarre A, Bengesser S, Bhattacharjee AK, Biernacka JM, Birner A, Brichant-Petitjean C, Bui ET, Cervantes P, Chen GB, Chen HC, Chillotti C, Cichon S, Clark SR, Colom F, Cousins DA, Cruceanu C, Czerski PM, Dantas CR, Dayer A, Étain B, Falkai P, Forstner AJ, Frisén L, Fullerton JM, Gard S, Garnham JS, Goes FS, Grof P, Gruber O, Hashimoto R, Hauser J, Herms S, Hoffmann P, Hofmann A, Jamain S, Jiménez E, Kahn JP, Kassem L, Kittel-Schneider S, Kliwicki S, König B, Kusumi I, Lackner N, Laje G, Landén M, Lavebratt C, Leboyer M, Leckband SG, Jaramillo CAL, MacQueen G, Manchia M, Martinsson L, Mattheisen M, McCarthy MJ, McElroy SL, Mitjans M, Mondimore FM, Monteleone P, Nievergelt CM, Nöthen MM, Ösby U, Ozaki N, Perlis RH, Pfennig A, Reich-Erkelenz D, Rouleau GA, Schofield PR, Schubert KO, Schweizer BW, Seemüller F, Severino G, Shekhtman T, Shilling PD, Shimoda K, Simhandl C, Slaney CM, Smoller JW, Squassina A, Stamm T, Stopkova P, Tighe SK, Tortorella A, Turecki G, Volkert J, Witt S, Wright A, Young LT, Zandi PP, Potash JB, DePaulo JR, Bauer M, Reininghaus EZ, Novák T, Aubry JM, Maj M, Baune BT, Mitchell PB, Vieta E, Frye MA, Rybakowski JK, Kuo PH, Kato T, Grigoroiu-Serbanescu M, Reif A, Del Zompo M, Bellivier F, Schalling M, Wray NR, Kelsoe JR, Alda M, Rietschel M, McMahon FJ, Schulze TG.

Lancet. 2016 Mar 12;387(10023):1085-1093. doi: 10.1016/S0140-6736(16)00143-4. Epub 2016 Jan 22.

47.

Characterizing the phenotype of multiple sclerosis-associated depression in comparison with idiopathic major depression.

Hasselmann H, Bellmann-Strobl J, Ricken R, Oberwahrenbrock T, Rose M, Otte C, Adli M, Paul F, Brandt AU, Finke C, Gold SM.

Mult Scler. 2016 Oct;22(11):1476-1484. Epub 2016 Jan 8.

PMID:
26746809
48.

Correction: Ethanolamine Signaling Promotes Salmonella Niche Recognition and Adaptation during Infection.

Anderson CJ, Clark DE, Adli M, Kendall MM.

PLoS Pathog. 2015 Dec 18;11(12):e1005365. doi: 10.1371/journal.ppat.1005365. eCollection 2015 Dec. No abstract available.

49.

Alterations in neural Theory of Mind processing in euthymic patients with bipolar disorder and unaffected relatives.

Willert A, Mohnke S, Erk S, Schnell K, Romanczuk-Seiferth N, Quinlivan E, Schreiter S, Spengler S, Herold D, Wackerhagen C, Romund L, Garbusow M, Lett T, Stamm T, Adli M, Heinz A, Bermpohl F, Walter H.

Bipolar Disord. 2015 Dec;17(8):880-91. doi: 10.1111/bdi.12352. Epub 2015 Dec 15.

PMID:
26667844
50.

The FKBP5 polymorphism rs1360780 influences the effect of an algorithm-based antidepressant treatment and is associated with remission in patients with major depression.

Stamm TJ, Rampp C, Wiethoff K, Stingl J, Mössner R, O Malley G, Ricken R, Seemüller F, Keck M, Fisher R, Gaebel W, Maier W, Möller HJ, Bauer M, Adli M.

J Psychopharmacol. 2016 Jan;30(1):40-7. doi: 10.1177/0269881115620459. Epub 2015 Dec 8.

PMID:
26645208

Supplemental Content

Support Center